Contact and Support

Clinicians and neurology departments evaluating Delphi-MD for their practice, health systems and brain health networks planning a rollout, research teams designing a study, and partnership or media enquiries. Choose the matching subject in the form so your request reaches the right people.

Yes. Request a demonstration through the form and our team will arrange a session, on site or remote, walking through the assessment workflow, the report a clinician receives, and how the results sit alongside the brain evaluation tools you already use.

In the United States, Delphi-MD has been granted FDA de novo classification, making it available for clinical practice. In the European Union it holds CE MDR approval under the Medical Device Regulation. Deployment runs through neurological care centers, neurology departments and brain health networks. For availability anywhere else, ask us and we will tell you where things stand.

Yes. Delphi-MD is used in investigator-led studies with academic partners, among them the Department of Neurology and Rehabilitation at the University of Illinois Chicago and the Sheba Longevity Center. Describe your protocol and endpoints in the form and we will come back to you on feasibility.

Peer-reviewed publications, white papers and conference material are collected in our Resources section. The work on Parkinson’s disease subtyping, for example, was published in npj Parkinson’s Disease. If you need something specific for an evaluation or a tender, ask and we will send it.